After a systematic review of all publications on recurrent pericarditis from 1966 to 2006, we identified 8 major clinical series including a total of 230 patients with idiopathic recurrent pericarditis (mean age 46 years, men/women ratio: 0.9). After a mean follow-up of 61 months, the complication rate was 3.5% cardiac tamponade and 0% constrictive pericarditis and left ventricular dysfunction. The overall life prognosis is excellent in idiopathic recurrent pericarditis and complications are uncommon. In conclusion constrictive pericarditis was never reported despite numerous recurrences, and the risk is lower than in idiopathic acute pericarditis (approximately 1%). Thus, it is important to reassure patients on their prognosis, explaining the nature of the disease, and the likely course. Therapeutic choices should take into account of the overall good outcome of these patients, including less toxic agents.
Prognosis of Idiopathic Recurrent Pericarditis as Determined from Previously Published Reports / M. Imazio, A. Brucato, Y. Adler, G. Brambilla, G. Artom, E. Cecchi, G. Palmieri, R. Trinchero. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 100:6(2007), pp. 1026-1028.
Prognosis of Idiopathic Recurrent Pericarditis as Determined from Previously Published Reports
A. Brucato;
2007
Abstract
After a systematic review of all publications on recurrent pericarditis from 1966 to 2006, we identified 8 major clinical series including a total of 230 patients with idiopathic recurrent pericarditis (mean age 46 years, men/women ratio: 0.9). After a mean follow-up of 61 months, the complication rate was 3.5% cardiac tamponade and 0% constrictive pericarditis and left ventricular dysfunction. The overall life prognosis is excellent in idiopathic recurrent pericarditis and complications are uncommon. In conclusion constrictive pericarditis was never reported despite numerous recurrences, and the risk is lower than in idiopathic acute pericarditis (approximately 1%). Thus, it is important to reassure patients on their prognosis, explaining the nature of the disease, and the likely course. Therapeutic choices should take into account of the overall good outcome of these patients, including less toxic agents.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0002914907011836-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
63.35 kB
Formato
Adobe PDF
|
63.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.